Tema Heart & Health ETF (NASDAQ:HRTS) Shares Down 1.5% – Time to Sell?

Tema Heart & Health ETF (NASDAQ:HRTS) shares traded down 1.5% on Tuesday . The stock traded as low as $35.00 and last traded at $35.21. 6,130 shares traded hands during trading, a decline of 30% from the average session volume of 8,784 shares. The stock had previously closed at $35.75.

Tema Heart & Health ETF Price Performance

The stock has a market capitalization of $55.98 million, a price-to-earnings ratio of 22.06 and a beta of 0.97. The business’s fifty day moving average price is $35.80 and its 200-day moving average price is $33.64.

Tema Heart & Health ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Thursday, December 11th. Shareholders of record on Wednesday, December 10th were paid a dividend of $0.4729 per share. The ex-dividend date was Wednesday, December 10th.

Institutional Trading of Tema Heart & Health ETF

Several institutional investors and hedge funds have recently modified their holdings of the stock. Kestra Advisory Services LLC purchased a new position in shares of Tema Heart & Health ETF during the fourth quarter valued at approximately $27,000. JPMorgan Chase & Co. purchased a new stake in Tema Heart & Health ETF in the 2nd quarter valued at $63,000. Jane Street Group LLC lifted its stake in Tema Heart & Health ETF by 9.4% during the 2nd quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after acquiring an additional 3,202 shares in the last quarter. Stifel Financial Corp lifted its stake in Tema Heart & Health ETF by 19.8% during the 4th quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock valued at $1,187,000 after acquiring an additional 5,571 shares in the last quarter. Finally, Citadel Advisors LLC purchased a new position in Tema Heart & Health ETF during the 3rd quarter worth $243,000.

About Tema Heart & Health ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.